Source Post
Top Pharma Stocks: Deep Dive with a Former Worker Part 1
Nov 27, 2025
The creator, a former pharmaceutical industry insider, discusses the sector's challenges, particularly the impact of Medicare negotiating lower drug prices. While generally avoiding pharma stocks, he will analyze popular companies under duress, starting with Novo Nordisk and its drug Ozempic, highlighting the potential for reduced revenue due to price cuts.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.